by acaballero | Nov 18, 2025 | Industry insights
Written by Paloma Charlesworth (Assistant Project Manager) Background Health inequalities are systematic, avoidable, and unjust differences in health outcomes between patient groups. Despite decades of policy and research, they not only persist but in some...
by Dom Partridge | Oct 31, 2025 | Industry insights
By Kiera Lander October brought real movement across the health technology assessment (HTA) landscape — not just in HealthTech, but across medicines, strategy, and international collaboration. From National Institute for Health and Care Excellence (NICE)...
by Dom Partridge | Oct 21, 2025 | Industry insights
Written by Gwennie Ogilby (Associate Systematic Review Analyst) and Tom Metcalf (Senior Systematic Review Analyst) Systematic literature reviews (SLRs) are considered one of the strongest forms of evidence to guide healthcare policy and inform future research....
by Dom Partridge | Oct 16, 2025 | Industry insights
Written by Dan Spacie, CEO of SCIRIS Executive Summary Market access services are undergoing a dual transformation. On one hand, technological advances and procurement pressures are driving commoditisation—standardising deliverables and compressing margins. On...
by Dom Partridge | Sep 5, 2025 | Industry insights
Written by Luke Parkes Introduction Newborn screening (NBS) is an impactful public health initiative that enables the diagnosis of severe conditions in asymptomatic infants at birth. Typically, NBS programmes include testing for a select number of metabolic and...
by Dom Partridge | May 30, 2025 | Industry insights
Written by Brian O’Toole The National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies (HST) programme is designed to evaluate innovative treatments for rare and complex conditions. On 19th March 2025, NICE announced several...
